Chinese researchers have developed a wearable dopamine patch that could help monitor depression and Parkinson's disease by ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
NFL players face nearly four times higher neurodegenerative disease mortality, with dementia and Parkinson's disease deaths ...
4don MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
Designer babies who are genetically engineered for desirable health, physical, and intellectual features are now within reach ...
Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...
King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world's first protocol of its kind, using an algorithm to accurately estimate the expected ...
Climate Compass on MSN
The "longevity gene" race: Why scientists are split on which species ages slowest
Ask ten biologists which animal ages the slowest and you might get ten different answers, along with a polite argument about ...
The Manila Times on MSNOpinion
There is only one acceptable path for designer babies
BOSTON, Massachusetts — Designer babies who are genetically engineered for desirable health, physical and intellectual ...
Scientists have discovered an important clue that may explain why some people with leukemia also develop autoimmune diseases.
The failure of AstraZeneca and Ionis’ Wainua in a late-stage study of ATTR-CM casts doubt on Alnylam’s next-generation candidate but is good news for others in the space, including BridgeBio and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results